Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma

被引：0
|
作者：
Walewski, Jan [1 ]
Paszkiewicz-Kozik, Ewa [1 ]
Warszewska, Agnieszka [1 ]
Borsaru, Gabriela [2 ]
Moicean, Andreea [3 ]
Hellmann, Andrzej [4 ]
Mayer, Jiri [5 ,6 ]
Hauns, Bernhard [7 ]
Mais, Anna [7 ]
Henning, Stefan W. [7 ]
Hentsch, Bernd [7 ]
机构：
[1] Maria Sklodowska Curie Mem Inst & Oncol Ctr, Warsaw, Poland
[2] Spitalul Clin Coltea, Bucharest, Romania
[3] Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania
[4] Med Univ Gdansk, Gdansk, Poland
[5] Univ Hosp Brno, Dept Internal Med Hematooncol, Brno, Czech Republic
[6] CEITEC Masaryk Univ, Brno, Czech Republic
[7] 4SC AG, Martinsried, Germany
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1149 / 1149
页数：1
相关论文
共 50 条
  • [41] Phase II Study of Brentuximab Vedotin Plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma
    Chen, Robert W.
    Palmer, Joycelynne M.
    Herrera, Alex Francisco
    Armenian, Saro H.
    Mei, Matthew
    Popplewell, Leslie
    Fueger, Abbey
    Qasim, Imran
    Stiller, Tracy
    Rosen, Steven T.
    Forman, Stephen J.
    Kwak, Larry W.
    BLOOD, 2017, 130
  • [42] Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
    Maruyama, Dai
    Hatake, Kiyohiko
    Kinoshita, Tomohiro
    Fukuhara, Noriko
    Choi, Ilseung
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Terui, Yasuhito
    Higuchi, Yusuke
    Onishi, Yasushi
    Abe, Yasunobu
    Kobayashi, Tsutomu
    Shirasugi, Yukari
    Tobinai, Kensei
    CANCER SCIENCE, 2017, 108 (05) : 1007 - 1012
  • [43] Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease
    Younes, A
    Pro, B
    Robertson, MJ
    Flinn, IW
    Romaguera, JE
    Hagemeister, F
    Dang, NH
    Fiumara, P
    Loyer, EM
    Cabanillas, FF
    McLaughlin, PW
    Rodriguez, MA
    Samaniego, F
    CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5432 - 5438
  • [44] FINAL RESULTS OF THE HDR2 STUDY - A EUROPEAN MULTICENTER TRIAL IN PATIENTS WITH RELAPSED HODGKIN LYMPHOMA
    Engert, M.
    Haverkamp, H.
    Borchmann, P.
    Mueller, H.
    Diehl, V.
    Doehner, H.
    Metzner, B.
    Franke, A.
    Smardova, L.
    Niederwieser, D.
    Wilhelm, M.
    Goebeler, M. -E
    Schmitz, N.
    Sureda, A.
    Baars, J. W.
    Raemaekers, J.
    Josting, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 204 - 204
  • [45] Final results of a phase II trial of R-IDEA as salvage therapy in patients with relapsed/refractory diffuse large B-cell lymphoma
    Kondo, E.
    Yamamoto, K.
    Masunari, T.
    Takizawa, J.
    Miura, K.
    Masaki, Y.
    Matsumura, T.
    Hiramatsu, Y.
    Murakam, J.
    Tsujimura, H.
    Tomita, N.
    Maeda, Y.
    Kanno, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)
    Song, Yuqin
    Zhou, Keshu
    Jin, Chuan
    Qian, Zhengzi
    Hou, Ming
    Fan, Lei
    Li, Fei
    Ding, Kaiyang
    Zhou, Hui
    Li, Xiaoling
    Chen, Bing
    Sun, Xiuhua
    Song, Xianmin
    Jiang, Ming
    Zhang, Qingyuan
    Liu, Lihong
    Yu, Guohua
    Hu, Yu
    Zhao, Zheng
    Liu, Ligen
    Xue, Hongwei
    Luo, Jun
    He, Bai
    Jin, Xiaoping
    Zhao, Min
    Li, Baiyong
    Xia, Yu
    Zhu, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Final Results of a Phase II Trial with Plitidepsin (Aplidin) Alone and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Mateos, Maria-Victoria
    Cibeira, Teresa
    Richardson, Paul
    Blade, Joan
    Prosper, Felipe
    Oriol, Albert
    de la Rubia, Javier
    Alegre, Adrian
    Lahuerta, Juan Jose
    Garcia-Sanz, Ramon
    Mitsiades, Constantine S.
    Espinoza, Jose
    Anderson, Kenneth C.
    Miguel, J. F. San
    BLOOD, 2008, 112 (11) : 1268 - 1268
  • [48] Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma
    Shah, Jatin J.
    Orlowski, Robert Z.
    Thomas, Sheeba K.
    Alexanian, Raymond
    Wang, Michael
    Qazilbash, Muzaffar H.
    Popat, Uday R.
    Parmar, Simrit
    Shah, Nina
    Bashir, Qaiser
    Champlin, Richard E.
    Weber, Donna M.
    BLOOD, 2012, 120 (21)
  • [49] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)
    Svoboda, Jakub
    Barta, Stefan K.
    Landsburg, Daniel J.
    Nasta, Sunita Dwivedy
    Hwang, Wei-Ting
    Delp, Grace
    Amundsen, Brittany
    Ballard, Hatcher J.
    Gerson, James N.
    Chong, Elise A.
    Hughes, Mitchell E.
    Emanuel, Steven A.
    Ruella, Marco
    Schuster, Stephen J.
    BLOOD, 2020, 136
12345